Actemra’s, an Arthritis Drug, Shows Promise of Treating Coronavirus - COVID-19 Clinical Trial
Breaking News | COVID-19

Actemra’s, an Arthritis Drug, Shows Promise of Treating Coronavirus

Roche Holding AG is supplying its arthritis drug Actemra to doctors on the front lines fighting the new coronavirus, Alexander Hardy, Chief Executive of Roche’s Genentech business, said during The Wall Street Journal Health Forum on Tuesday. Although Actemra has not gone under clinical trials as of yet, it shows great promise.

Share this:
Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on email
Scroll to Top

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.